About ViroGen
ViroGen is a Healthcare company based in Watertown (United States) founded in 1995 by Dmitry Blinder and David Perry. It provides antigens and antibodies for research and medical applications in biotechnology. It operates on a B2B model. The company has 1 employees. Its focus areas include Biotechnology, Life Sciences, Biotech Products and Antigens and Antibodies. Its legal entity is VIROGEN CORP. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
ViroGen operates with a B2B model, focusing on advancing biotech innovations, life sciences, biotech products, and antigens and antibodies. Provides antigens and antibodies for research and medical applications in biotechnology. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Watertown, United States
- Employees 1
- Founders Dmitry Blinder, David Perry
- SectorsHealthcare
- Website virogen.com
- Social X Facebook
- Legal Name Virogen Corp.
- Employee Count1
People of ViroGen
2 people are tracked at ViroGen (2 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Dmitry Blinder | Co-Founder | Leadership |
David Perry | Co-Founder, President | Leadership |
Complete people profiles for ViroGen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of ViroGen
ViroGen has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of ViroGen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as ViroGen (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ViroGen
ViroGen was founded in 1995.
ViroGen is headquartered in Watertown, United States.
ViroGen has 1 employees.
ViroGen operates with a B2B model, focusing on advancing biotech innovations, life sciences, biotech products, and antigens and antibodies. Provides antigens and antibodies for research and medical applications in biotechnology. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
ViroGen's top competitors include GenScript, Epitomics and Vector Laboratories.
ViroGen operates through Virogen Corp..